BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 13833508)

  • 1. Treatment of varlous hematologic disorders: use of triamcinolone.
    SPURR CL; HAYES DM
    Am Pract Dig Treat; 1959 Dec; 10():2113-22. PubMed ID: 13833508
    [No Abstract]   [Full Text] [Related]  

  • 2. Flow cytometry in hematological disorders.
    Pati HP; Jain S
    Indian J Pediatr; 2013 Sep; 80(9):772-8. PubMed ID: 23943573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical use of methylprednisolone in certain hematologic disorders.
    YUNIS AA; HARRINGTON WJ
    Metabolism; 1958 Jul; 7(4 Pt 2):543-68. PubMed ID: 13565414
    [No Abstract]   [Full Text] [Related]  

  • 4. WEEKLY HIGH-DOSAGE GLUCOCORTICOSTEROID TREATMENT OF LYMPHOCYTIC LEUKEMIAS AND LYMPHOMAS.
    BURNINGHAM RA; RESTREPO A; PUGH RP; BROWN EB; SCHLOSSMAN SF; KHURI PD; LESSNER HE; HARRINGTON WJ
    N Engl J Med; 1964 May; 270():1160-6. PubMed ID: 14129063
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prednisone and hemopathy].
    POLLI E; CROSTI PF; CARRARA PM
    Minerva Med; 1955 Dec; 46(99):1723-8. PubMed ID: 13288093
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of the adrenocorticotropic hormone (ACTH) in acquired hemolytic anemia, agranulocytosis, thrombopenia and lymphosarcomatous leukemia.
    TISCHENDORF W; MULLER K
    Dtsch Med Wochenschr; 1954 Oct; 79(44):1622-7. PubMed ID: 13220134
    [No Abstract]   [Full Text] [Related]  

  • 7. [A case of congenital hemolytic disease followed up for 24 years; splenectomy, vesicular lithiasis (Coombs test positive); immunology].
    BERNARD A; HENNINOT E
    J Sci Med Lille; 1952 Nov; 70(20-21):469-76. PubMed ID: 13023775
    [No Abstract]   [Full Text] [Related]  

  • 8. [Splenectomy for hematologic indications. Indications, early results (author's transl)].
    Charleux H; Julien M; Bousquet R; Ribardière JL; Fagniez PL; Izrael V
    J Chir (Paris); 1977; 114(6):413-26. PubMed ID: 608848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematologic manifestations of malignant disease.
    NORCROSS JW
    Med Clin North Am; 1963 Mar; 47():345-52. PubMed ID: 13938872
    [No Abstract]   [Full Text] [Related]  

  • 10. [FREQUENCY OF CHANGES IN THE PLASTICITY AND SENSITIZATION OF ERYTHROCYTES BY AUTOANTIBODIES IN DIFFERENT BLOOD DISEASES. (3 YEARS OF CLINICAL EXPERIENCE IN THE USE OF THE ERYTHROCYTE FILTERABILITY TEST)].
    NICOLAU CT; TEITEL P; FOTINO M; BUTOIANU E; TAIGAR S
    Med Interna (Bucur); 1964 Aug; 16():907-15. PubMed ID: 14192598
    [No Abstract]   [Full Text] [Related]  

  • 11. Haematological disorders.
    Willoughby ML
    Clin Obstet Gynaecol; 1977 Aug; 4(2):371-95. PubMed ID: 340106
    [No Abstract]   [Full Text] [Related]  

  • 12. [ELECTROCARDIOGRAPHIC STUDY DURING SOME BLOOD DISEASES IN CHILDHOOD].
    COLETTA A
    Pediatria (Napoli); 1963; 71():561-77. PubMed ID: 14051031
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug-induced hematologic complications].
    Maj S
    Acta Physiol Pol; 1979; 30 Suppl 19():119-29. PubMed ID: 575599
    [No Abstract]   [Full Text] [Related]  

  • 14. [Perspectives for the use of gene therapy in blood disorders].
    Jedrzejczak WW
    Pol Arch Med Wewn; 2002 May; 107(5):475-9. PubMed ID: 12189921
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hematologic neoplasms: clinically latent--but needing treatment?].
    Huber H; Fasching B; Drach J; Thaler J
    Verh Dtsch Ges Inn Med; 1990; 96():138-47. PubMed ID: 2092432
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of recombinant interleukin-2 in therapy for hematologic malignancies.
    Dutcher JP; Wiernik PH
    Semin Oncol; 1993 Dec; 20(6 Suppl 9):33-40. PubMed ID: 8284690
    [No Abstract]   [Full Text] [Related]  

  • 17. Interleukin-2 therapy after autologous bone marrow transplantation for hematologic malignancies.
    Fefer A; Benyunes MC; Massumoto C; Higuchi C; York A; Buckner CD; Thompson JA
    Semin Oncol; 1993 Dec; 20(6 Suppl 9):41-5. PubMed ID: 8284691
    [No Abstract]   [Full Text] [Related]  

  • 18. [STUDIES ON THE BEHAVIOR OF THE PROPERDIN AND COMPLEMENT LEVELS IN DISEASES OF THE HEMATOPOIETIC SYSTEM].
    BRAGIEL I; JASSER S; KOLAKOWSKA K; KRZEMINSKA LAWKOWICZOWA I; POLUBIEC A; ROSTKOWSKA J
    Pol Arch Med Wewn; 1963; 33():1359-67. PubMed ID: 14121549
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hematopoietic factors: cytokine].
    Hirashima K
    Nihon Naika Gakkai Zasshi; 1994 Mar; 83(3):368-72. PubMed ID: 7525808
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemosorption detoxication in the combined treatment of hematological patients].
    Starikov AV; Kushko OV; Klimenko VI
    Vrach Delo; 1983 Feb; (2):70-4. PubMed ID: 6845703
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.